Risk factors for hospital mortality of patients with COVID-19 and 6-month follow-up of discharged patients

Objective: COVID-19 continues to pose a public health threat globally. This study evaluated the risk factors of hospitalized patients associated with hospital mortality for COVID-19 and symptoms on days 14, 28, and 6th-month. Methods: The study included 133 adults hospitalized due to COVID-19 betwee...

Full description

Saved in:
Bibliographic Details
Published in:Dicle tıp dergisi 2022-12, Vol.49 (4), p.579-589
Main Authors: ARSLAN GÜLEN, Tugba, İMRE, Ayfer, BOZOK, Taylan
Format: Article
Language:English
Subjects:
Comorbidity
Coronaviruses
COVID-19
Demographics
Diabetes
Ethics
Fatigue
Hospitalization
Hypertension
Laboratories
Lymphocytes
Mortality
Oxygen saturation
Patients
Pneumonia
Proteins
Public health
Risk factors
Severe acute respiratory syndrome coronavirus 2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: COVID-19 continues to pose a public health threat globally. This study evaluated the risk factors of hospitalized patients associated with hospital mortality for COVID-19 and symptoms on days 14, 28, and 6th-month. Methods: The study included 133 adults hospitalized due to COVID-19 between April 1, 2020 and June 30, 2020. Patient files were retrospectively reviewed. The demographic characteristics of the patients were evaluated by dividing them into two groups according to the clinical severity of COVID-19. (group 1: mild+moderate, group 2: severe+critical). Risk factors associated with mortality were revealed. Symptoms on day 14 and day 28 were questioned in person or by phone if patients were discharged and symptoms at 6 months were questioned by phone. Results: Comparison of laboratory findings between the groups showed that patients in group 2 had lower serum lymphocyte count and higher levels of C-reactive protein, ferritin, D-dimer, procalcitonin, and troponin T at admission and during follow-up (p
ISSN:1300-2945
1308-9889
DOI:10.5798/dicletip.1220745